In-vitro and in-vivo studies on a topical formulation of sitamaquine dihydrochloride for cutaneous leishmaniasis

by Garnier T, Brown MB, Lawrence MJ, Croft SL. J Pharm Pharmacol, August 2006, 58(8):1043-54.

Summary: The efficacy of topical formulations of the 8-aminoquinoline, sitamaquine dihydrochloride, in both in vitro and in in-vivo models of cutaneous leishmaniasis is reported.

Click here to access the full article